ASPG and acute lymphoblastic leukemia: ALL induction therapy according to e.g. the AIEOP-BFM ALL 2017 protocol [1] combines high-dose steroids, vincristine, daunorubicin and asparaginase and remission is achieved in most patients after 33 days of treatment, monitored by measurable residual disease (MRD) using clonotypic markers.